{
    "2019-02-13": [
        [
            {
                "time": "2018-01-03",
                "original_text": "Key Takeaways from Eli Lilly's (LLY) Q4 Earnings Report",
                "features": {
                    "keywords": [
                        "Eli Lilly",
                        "Q4 Earnings",
                        "Takeaways"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-05",
                "original_text": "Moat Index: Dramatic Sector Allocation Shift in 2018",
                "features": {
                    "keywords": [
                        "Moat Index",
                        "Sector Allocation",
                        "Shift"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "diversified"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-01-08",
                "original_text": "J&J's (JNJ) Depression Treatment Gets FDA Committee's Nod",
                "features": {
                    "keywords": [
                        "J&J",
                        "Depression Treatment",
                        "FDA Nod"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-10",
                "original_text": "The Zacks Analyst Blog Highlights: Disney, Eli Lilly, U.S. Bancorp, Prudential and Alexion",
                "features": {
                    "keywords": [
                        "Zacks Analyst",
                        "Disney",
                        "Eli Lilly",
                        "U.S. Bancorp",
                        "Prudential",
                        "Alexion"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "diversified"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-12",
                "original_text": "5 Tiny Biotech Stocks With Superb Growth Potential",
                "features": {
                    "keywords": [
                        "Biotech Stocks",
                        "Growth Potential"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-15",
                "original_text": "What Are the Key Growth Drivers for Eli Lilly in Fiscal 2019?",
                "features": {
                    "keywords": [
                        "Eli Lilly",
                        "Growth Drivers",
                        "Fiscal 2019"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-02-14",
                "original_text": "Eli Lilly and Company (LLY) Ex-Dividend Date Scheduled for February 14, 2019",
                "features": {
                    "keywords": [
                        "Eli Lilly",
                        "Ex-Dividend Date",
                        "February 14"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-18",
                "original_text": "Pfizer and Eli Lilly: How Dividends and Tax Rates Stack Up",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "Eli Lilly",
                        "Dividends",
                        "Tax Rates"
                    ],
                    "sentiment_score": 0.65,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-01-20",
                "original_text": "Pfizer or Eli Lilly: Who Is Controlling Expenses Better?",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "Eli Lilly",
                        "Expenses Control"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-01-22",
                "original_text": "Earnings Reaction History: Eli Lilly & Co., 50.0% Follow-Through Indicator, 2.4% Sensitive",
                "features": {
                    "keywords": [
                        "Earnings Reaction",
                        "Eli Lilly",
                        "Follow-Through Indicator",
                        "Sensitive"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}